Ketamine Vapes: What's Actually in Them and the Risks

Not medical advice. This article is for harm reduction and educational purposes only. Nothing here is a recommendation to use any substance. If you are experiencing a medical emergency, call your local emergency services immediately. Some links may be affiliate links — we earn a small commission at no cost to you.

Ketamine vapes — vape pens sold or distributed as containing ketamine — have been appearing at festivals and online markets. The core problem is straightforward: most of them almost certainly do not contain real ketamine, and whatever they do contain is unlabeled, untested, and uncontrolled. This post covers the chemistry of why vaping ketamine is harder than it sounds, what novel dissociatives are typically found in these products instead, the specific dangers of inhaling unknown chemical compounds, and what the harm reduction approach looks like.

Quick answers

Do ketamine vapes actually contain ketamine? Unlikely in most cases. Pharmaceutical-grade ketamine can be delivered by inhalation, but the chemistry of vape pens makes vaporizing ketamine HCl (the form found on the street) inefficient. Products sold without pharmaceutical labeling more commonly contain novel dissociative research chemicals.

What is more likely inside a ketamine vape? Research chemicals including 2-fluorodeschloroketamine (2-FDCK), deschloroketamine (DCK), or methoxetamine (MXE) — ketamine analogs that are more volatile and easier to vaporize, but have thinner safety data and documented fatalities.

Are ketamine vapes dangerous? Yes, for multiple reasons: unknown substance identity, no dose control, no purity data, lung toxicity from vaping chemical carriers, and the risk profile of novel dissociatives at unknown concentrations.

How can I tell what’s in a vape? Standard colorimetric reagent tests (Marquis, Simon’s) are unreliable for distinguishing ketamine from analogs in a vape formulation. FTIR or GC/MS drug checking is the only reliable method. DanceSafe and other drug checking services provide access to spectrometry at some festivals.

Is vaping ketamine the same as snorting it? No. The pharmacokinetics, absorption rate, and effective dose are different across routes. Inhaled dosing is harder to control than intranasal, where you can measure visible volume increments.

Can ketamine actually be vaped?

The short answer is yes — with the right formulation and temperature. Clinical research on inhaled esketamine (the S-enantiomer of ketamine) has established that inhalation is a viable delivery route with measurable bioavailability (PMID 28759464). Pharmaceutical inhalation formulations use nebulizers that produce fine aqueous droplets optimized for lung absorption.

Vape pens work differently. They heat a substance to vaporization temperature. Ketamine hydrochloride — the salt form found in street powder — has a melting point of approximately 252–254°C and a boiling point around 364°C. Standard vape pen heating elements operate at 200–250°C. At those temperatures, ketamine HCl does not vaporize efficiently; it partially degrades and what does aerosolize is inconsistent.

Ketamine freebase has a lower vaporization point and could theoretically be used in a vape formulation, but converting street ketamine HCl to freebase requires chemical processing. A product labeled “ketamine vape” sold informally has almost certainly not gone through that process.

The practical implication: if you inhale a “ketamine vape” and feel dissociative effects, those effects are probably not coming from ketamine.

What’s more likely inside

The novel dissociative research chemical market has grown directly alongside demand for ketamine substitutes. The most commonly documented analogs in circulation are:

2-Fluorodeschloroketamine (2-FDCK) is the most prevalent ketamine analog currently documented in drug seizures and toxicology. A 2020 forensic study from Hong Kong (PMID 32460225) documented 20 analytically confirmed cases of 2-FDCK exposure in a single seven-month period; 19 of those 20 samples also contained at least one additional ketamine-type analog, and 90% also contained actual ketamine — meaning users typically received a mixture, not a pure substitute. In a 2024 review of Hong Kong drug seizures (PMID 38850618), 2-FDCK was physically indistinguishable from ketamine and frequently sold as ketamine or as an “enhanced” substitute. 2-FDCK has been associated with two documented deaths and a case of drug-induced self-mutilation in a 2024 forensic case series (PMID 38619360).

Deschloroketamine (DCK) is a structural analog with higher potency than ketamine by weight and a longer duration of action. Forensic method development papers have documented DCK in blood and hair samples from toxicology cases, including a suicide involving multiple dissociative NPS (PMID 33971504). Higher potency per milligram means that at the same volume dose as ketamine, DCK produces stronger and longer-lasting effects — which is relevant to vape pens where dose per puff is uncalibrated.

Methoxetamine (MXE) was the first major ketamine substitute to gain widespread use, marketed explicitly as a “legal, bladder-friendly” alternative to ketamine. A 2016 review (PMID 27128862) documented serious adverse effects including psychosis, cerebellar toxicity (uncoordinated movement persisting for days), and fatal intoxication cases. Emergency department presentations involving MXE included sympathomimetic features — elevated heart rate and blood pressure — not typical of ketamine (PMID 22205276). MXE is now controlled in many countries; whether it has been replaced by 2-FDCK or DCK in local markets varies by region.

Unknown substances. Drug checking data consistently shows that a meaningful percentage of samples submitted as ketamine are not ketamine. A study of an international cryptomarket drug testing service found ketamine purity averaged 71% among submitted samples (PMID 27239011). A 2021 Italian festival drug checking study found that only 78% of samples submitted as ketamine confirmed as ketamine by GC/MS (PMID 33692707). A “ketamine vape” with no pharmaceutical provenance or third-party testing has no verified contents at all.

The lung risk: vaping unknown chemicals

The 2019–2020 EVALI outbreak (e-cigarette or vaping product use-associated lung injury) established clearly that vaping unverified liquid formulations can cause severe, life-threatening lung injury. The canonical epidemiological study (PMID 31491072) documented 87% of cases involved THC vape products from informal sources. The mechanistic companion paper (PMID 31860793) identified vitamin E acetate — used as an oil diluent in black-market THC cartridges — as the causal agent, detected in 94% of EVALI patients’ lung fluid versus zero of 99 controls.

The lesson is not that vaping THC is specifically dangerous. It is that vaping any chemical of unknown composition from an unverified source carries serious lung toxicity risk. The carrier solvents, diluents, and cutting agents used in illicit vape products are the risk — and those are never disclosed on an unlabeled product. A novel dissociative dissolved in an undisclosed solvent and heated to vapor in an unregulated device is a completely unknown inhalation exposure. No safety data exists for any of those compounds administered via this route.

Testing: what works and what doesn’t

Standard colorimetric reagent tests are unreliable for distinguishing ketamine from its analogs in a vape liquid format. Marquis and Mecke may produce reactions consistent with a dissociative compound but cannot distinguish ketamine from 2-FDCK, DCK, or MXE — the structural differences are too similar for reagent colorimetry to resolve.

The only reliable testing for this class of substances is FTIR or GC/MS spectrometry. Some harm reduction organizations and festival drug checking services have access to these instruments. Drug checking at music festivals (PMID 31605958) has demonstrated meaningful discrepancies between what people believe they have and what spectrometry confirms.

The DanceSafe complete testing kit includes Marquis, Mecke, Simon’s, and other reagents — useful for many substances, but the ketamine/analog limitation applies. If you are at a festival with on-site drug checking, use it. If you are not, reagent testing tells you less here than it does for MDMA or psilocybin.

The harm reduction bottom line

A “ketamine vape” from an unverified source should be treated as an unknown dissociative compound in an unknown carrier solvent, administered at an uncontrolled dose via inhalation. That combination removes nearly every harm reduction tool that makes dissociative use more manageable: known substance, measured dose, familiar pharmacokinetics.

If you are going to use ketamine, the harm reduction case for traditional routes — intranasal or oral, from a known source, with weighed doses — is significantly stronger than vaping an unlabeled product. The ketamine harm reduction guide covers dose ranges, the k-hole, bladder risks, and what makes ketamine sessions safer. For interactions with alcohol or other substances, see the ketamine and alcohol guide and the interaction checker.

The short version: if you cannot verify what is in a vape pen, you cannot make an informed decision about using it.